Bio Path Holdings News

BPTHDelisted Stock  USD 0.19  0.01  5.00%   
Under 61% of Bio Path's investor base is looking to short. The analysis of overall sentiment of trading Bio Path Holdings otc stock suggests that many investors are alarmed at this time. Bio Path's investing sentiment shows overall attitude of investors towards Bio Path Holdings.
  
over a week ago at benzinga.com         
US Stocks Mixed NY State Business Activity Rises In February
benzinga news
over two weeks ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Bio-Path Holdings Inc
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Bio-Path Holdings Provides Key Clinical Updates
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Bio-Path Holdings Provides Update from Phase 11b Clinical Trial of BP1002 for Treatment of Refractor...
Yahoo News
over two weeks ago at globenewswire.com         
Bio-Path Holdings Provides Update from Phase 11b Clinical Trial of BP1002 for Treatment of Refractor...
Macroaxis News: globenewswire.com
over two weeks ago at gurufocus.com         
Bio-Path Holdings Provides Update from Phase 11b Clinical Trial of BP1002 for Treatment of ...
Gurufocus Stories at Macroaxis
over three weeks ago at www.macroaxis.com         
Acquisition by Cleaver Heath of 10000 shares of Bio Path at 1. subject to Rule 16b-3
Macroaxis News
over a month ago at thelincolnianonline.com         
StockNews.com Begins Coverage on Bio-Path
news
over a month ago at gurufocus.com         
Bio-Path Holdings Provides 2025 Clinical and Operational Update
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Bio-Path Now Covered by Analysts at StockNews.com
news
over two months ago at thelincolnianonline.com         
Bio-Path Research Coverage Started at StockNews.com
news
over two months ago at gurufocus.com         
Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity ...
Gurufocus Stories at Macroaxis
over two months ago at benzinga.com         
Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline
benzinga news
over two months ago at benzinga.com         
Bio-Path Holdings Shares Were On The Rise Whats Going On?
benzinga news
over two months ago at gurufocus.com         
Bio-Path Holdings Surges Over 406 percent Following Positive Preclinical Study Results
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Bio Path that are available to investors today. That information is available publicly through Bio media outlets and privately through word of mouth or via Bio internal channels. However, regardless of the origin, that massive amount of Bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bio Path news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Path relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Path's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Path alpha.

Bio Path Performance against Dow Jones

 Price Growth (%)  
       Timeline  
Check out Bio Path Hype Analysis, Bio Path Correlation and Bio Path Performance.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Bio OTC Stock

If you are still planning to invest in Bio Path Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bio Path's history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Technical Analysis
Check basic technical indicators and analysis based on most latest market data